Back to Stakeholders

The Michael J. Fox Foundation for Parkinson's Research (MJFF) is a New York-based non-profit founded in 2000 by actor Michael J. Fox that has raised over $2 billion for Parkinson's disease research and treatments. MJFF has funded pioneering psychedelic research including the first psilocybin trial in a neurodegenerative disease (UCSF/Yale, for Parkinson's-related depression) and a ketamine infusion trial at Yale for treatment-resistant depression in Parkinson's patients.

Foundations & Philanthropy Snapshot

Psychedelic-Specific Foundations

Classification

Private Foundation

Geography

Global

Coverage

Global

Last Verified

Apr 10, 2026

Funding Focus Areas

Academic Research FundingClinical Trial Funding

Support Types

Grant Funding

Philanthropy Notes

Auto-backfilled baseline philanthropy profile from existing category tags and website. Manual enrichment recommended for recipient-level details.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Verification Notes

Verified against official MJFF grants pages.

Primary Funding Link

Quick Facts

Type
Non-Profit
HQ
United States
Website
Visit

Collaborated Trials

2